The two cut-offs approach for plasma p-tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairment.
Journal:
Alzheimer's & dementia (Amsterdam, Netherlands)
Published Date:
May 11, 2025
Abstract
BACKGROUND: The study aimed to explore the applicability of plasma phosphorylated tau (p-tau)217 in identifying patients with subjective cognitive decline (SCD) and mild cognitive impairment (MCI) carrying Alzheimer's disease (AD) pathology in real-world settings.
Authors
Keywords
No keywords available for this article.